ONP-04 delta 9-tetrahydrocannabinol hemisuccinate: Phase I

In a U.K. Phase I study in 30 healthy volunteers, ONP-04 delivered by rectal administration provided improved bioavailability compared to oral Marinol. Oxford Natural attributed the improvement to re...